Markets We Serve
Who we work for
Since our inception, we have primarily focused on crafting, bolstering, and supporting tailor-made logistic solutions for life science and healthcare industries, particularly in global temperature-controlled logistics. Moreover, we actively cover the top innovation sectors by accompanying the latest trends and areas in the Cell and Gene, Pharmaceutical, and Biopharmaceutical markets, from clinical to commercial locations.
It’s ingrained in our DNA. It constitutes our core business.
Today, we are pioneering innovative, unrivalled, and market-leading tailor-made solutions for a diverse clientele, encompassing:
- Pharmaceutical and Biotechnology organisations
- Clinical Research Organisations (CROs)
- Clinical Trial Laboratories
- Central Laboratories
- Research companies and Hospitals
- Individual researchers
What we do as a global temperature-controlled logistics
Our dedicated team is committed to providing extensive and cost-efficient logistics solutions encompassing significant transport, packaging, and tailor-made added-value services in these critical sectors.
Specializing in resolving complex challenges associated with temperature-sensitive, time-critical, or hazardous goods, we ensure meticulous and customized solutions precisely tailored to our clients’ unique needs.
Within the spectrum of clinical trials encompassing R&D and pre and clinical phases (Phase I to Phase IV and MAP), as well as the progression of Investigational Medical Products (IMPs), CRYOPDP’s global teams are dedicated to identifying and delivering temperature-controlled logistics and cold chain solutions precisely tailored to each unique clinical trial requirement.
This commitment ensures the seamless management of Investigational Medical Products, addressing the distinctive needs of each phase with utmost precision and effectiveness.
Moreover, our unparalleled expertise centres on global temperature-controlled logistics, specifically targeting temperature-controlled solutions for:
- Active Pharmaceutical Ingredients (APIs)
- Rare and Orphan disease drugs
- ATMP, cell, and gene samples
- Critical biosimilars
- Various therapeutic development
- Commercial drugs
Additionally, we fortify our expertise with a profound understanding of the intricacies surrounding the distribution process for these shipments. Our real-world experience enables us to minimize associated risks effectively.